Document:

Exhibit 10.13

 

INVESTMENT
AGREEMENT

 

THIS INVESTMENT AGREEMENT (this “Agreement”), dated
as of [•], 2022, is by and among (i) Sieger Healthcare Acquisition Corp, a Cayman Islands exempted company (the “SPAC”),
(ii) Sieger Healthcare LLC, a Cayman Islands limited liability company (the “Sponsor”), and (iii) [•]
(the “Investor”).

 

WHEREAS, the SPAC has filed with the U.S. Securities and Exchange
Commission (the “SEC”) a registration statement on Form S-1 (as amended, the “Registration Statement”)
for the initial public offering (the “IPO”) of units of the SPAC at a price of $10.00 per unit (the “Units”),
each comprised of one Class A ordinary share, par value $0.0001 per share, of the SPAC (the “Class A Shares”,
and the Class A Share included in the Units, the “Public Shares”) and one-third of one redeemable warrant, with
each whole warrant exercisable to purchase one Class A Share at an exercise price of $11.50 per share (the “Warrants”).

 

WHEREAS, the SPAC expects to offer at least 7,500,000 Units in the
IPO, plus an additional 15% (or 1,125,000Units) as an over-allotment option for the underwriter pursuant to the terms of the Underwriting
Agreement entered into in connection with the IPO.

 

WHEREAS, the SPAC will establish a Trust Account (the “Trust
Account”) for the benefit of its public shareholders upon the closing of the IPO, and such Trust Account of the SPAC will be
funded with an amount equal to 100% of the gross proceeds raised in the IPO.

 

WHEREAS, the SPAC will have up to 18 months from the closing of the
IPO to consummate its initial business combination (or up to or 24 months from the closing of the IPO if the Sponsor deposits additional
funds into the trust account).

 

WHEREAS, the Investor has expressed the interest to be a limited partner
in a certain fund (“Anchor”) managed by Haitong International Asset Management Limited.

 

WHEREAS, in connection with the IPO, the Anchor has expressed an interest
in acquiring at least [•] Units (such Units, the “IPO Indication”), at the initial public offering price of $10.00
per Unit.

 

WHEREAS, the parties wish to enter into this Agreement pursuant to
which, upon the terms and subject to the conditions hereof, the Investor will purchase from the Sponsor Class B ordinary shares,
par value $0.0001 per share, of the SPAC (the “Founder Shares”) at a purchase price of $ $0.009 per share. The Founder
Shares will convert into Class A Shares on a one-for-one basis, subject to adjustment, upon the terms and conditions set forth in
the memorandum and articles of association of the SPAC, as amended from time to time (the “Articles”).

 

     

     

    

 

NOW THEREFORE, the parties hereto hereby agree as follows:

 

		Section
                            1.	Sale and Purchase.

 

		(a)	In connection with the IPO Indication, and subject to the satisfaction
                                            of the conditions set forth in Section 1(b), the Sponsor hereby agrees to sell
                                            and transfer to the Investor [•] Founder Shares (the “Transferred Shares”)
                                            at a purchase price of $0.009 per share, or an aggregate purchase price of $[•]
                                            for the Transferred Shares (the “Transfer Price”), and the Investor hereby
                                            agrees to purchase the Transferred Shares (the “Investment”), on the completion
                                            of the Company’s initial Business Combination (as defined below) (“Business
                                            Combination Closing”). Concurrently with, and in consideration for, the sale and
                                            transfer of the Transferred Shares to the Investors, the Investor shall pay the Transfer
                                            Price to the Sponsor in immediately available funds. The SPAC shall update its register of
                                            the members of the SPAC to reflect the Transfer of the Transferred Shares as soon as practicable
                                            following the foregoing purchase and sale of the Transferred Shares. If the Business Combination
                                            Closing has not occurred by the date as set out in the Articles, or such later period approved
                                            by the Company’s shareholders in accordance with the Company’s Articles, then
                                            no Investment shall occur pursuant to this Section 1(a).

 

		(b)	Subject to (i) the fulfillment by the Anchor or its affiliates
                                            (but only to the extent actually allocated to the Anchor or its affiliates by the underwriters)
                                            of the IPO Indication (which shall include the acquisition of 100% of the Units of the SPAC
                                            allocated to the Anchor by the underwriters in the IPO, (ii) the Investor’s fulfilment
                                            of its obligations to the Anchor or its affiliates in relation to the IPO Indication, including
                                            the Investor’s investment of at least US$[•] into the Anchor and (iii) the
                                            Investor’s payment of the Transfer Price as contemplated by Section 1(a) of
                                            this Agreement, the Investment shall occur and be effective upon the Business Combination
                                            Closing, automatically and without any action of any party hereto.

 

		(c)	The SPAC shall register the Investor as the owner of the Transferred Shares with the SPAC’s transfer agent by book entry on
or promptly after the date of the Business Combination Closing, provided the Investor provides any and all information the transfer agent
reasonably and customarily requires to record such ownership (until such date, the Investor will be recorded on the SPAC’s book
or records).

 

		(d)	If either (i) the Anchor or its affiliate do not beneficially own or hold, directly or indirectly at least the number of Public
Shares it owns immediately after the IPO (the “Anchor Threshold”) as of the date of the vote by the Company’s
shareholders to approve the Business Combination or the business day immediately prior to the closing of the Business Combination or (ii) the
Anchor redeems all or a portion of its Public Shares in connection with the Business Combination that results in the Anchor and its affiliates
collectively owning less than the Anchor Threshold, then the number of Founder Shares that the Investor may purchase pursuant to Section 1(a) shall
be reduced pro rata by a fraction, the numerator of which shall equal the Anchor Threshold less the number of Public Shares held
by the Anchor after giving effect to any redemptions of the Public Shares by the Anchor and its affiliates, and the denominator of which
shall equal the Anchor Threshold (the “Ownership Reduction”). By way of example and without limiting the foregoing,
in the event the Anchor and its affiliates collectively own 50% or 0%, respectively, of the Anchor Threshold (after giving effect to any
redemptions of their Public Shares), the number of Founder Shares that the Investor may purchase pursuant to Section 1(a) shall
be reduced by 50% or 100%, respectively.

 

     2

     

    

 

		(e)	The Investor agrees that if, in order to facilitate a Business Combination, the Sponsor decides (i) to forfeit, transfer to a
third person, exchange, subject to transfer, vesting or conditional forfeiture provisions or amend the terms of all or any portion of
the Founder Shares or (ii) to enter into any other arrangements with respect to the Founder Shares (including, without limitation,
a transfer of the Sponsor’s membership interests representing an interest in any of the foregoing), including voting in favor of
any amendment to the terms of the Founder Shares (each, a “Change in Investment”), such Change in Investment shall
apply pro rata to the Investor and the Sponsor based on the relative number of Founder Shares to be purchased or held by each on
the Business Combination Closing; provided, however, that in no event shall such Change in Investment result in a reduction
of more than 75% of the Founder Shares to be purchased by the Investor pursuant to Section 1(a). By way of example and without
limiting the foregoing, in the event 50% or 100%, respectively, of the Sponsor’s Founder Shares are forfeited or transferred by
the Sponsor as part of such Business Combination, the number of Founder Shares that the Investor may purchase pursuant to Section 1(a) shall
be reduced by 50% or 75%, respectively. The Investor agrees to take all steps and execute all such agreements as may be necessary or reasonably
requested by the Sponsor to effectuate such Change in Investment on the same terms and conditions as applicable to the Sponsor.

 

		Section
                            2.	Representations and Warranties
of the SPAC. The SPAC hereby represents and warrants to the Investor, as follows:

 

		(a)	The SPAC is duly organized and in good standing (to the extent applicable) under its jurisdiction of organization and has full power
and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated
hereby.

 

		(b)	This Agreement has been duly and validly executed and delivered
by the SPAC and constitutes a legal, valid and binding obligation of the SPAC enforceable against the SPAC in accordance with its terms,
except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws
of general application affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies.

 

		(c)	The execution and delivery of this Agreement, the consummation of the transactions contemplated hereby and the performance by the
SPAC of its obligations hereunder will not conflict with, or result in any violation of or default under, (i) the certificate of
incorporation (as may be amended from time to time) or bylaws of the SPAC, (ii) any agreement, indenture or instrument to which the
SPAC is a party or by which the SPAC is bound, or any law, order, statute, rule or regulation to which the SPAC is or the Transferred
Shares are subject, or any agreement, order, judgment or decree to which the SPAC is or the Transferred Shares are subject.

 

     3

     

    

 

		(d)	No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority is required on the part of the SPAC in connection with the consummation of the transactions contemplated
by this Agreement (other than effectiveness of the Registration Statement for the offer and sale of Units in the IPO).

 

		(e)	None of the information conveyed to such Investor in connection with the transactions contemplated by this Agreement will constitute
material non-public information of the SPAC upon the effectiveness of the SPAC’s current Registration Statement, as amended.

 

		(f)	Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Articles, and registration in the register of
members of the SPAC, the Transferred Shares will be duly and validly issued, fully paid and non-assessable.

 

		(g)	There are no actions, suits, investigations or proceedings pending or threatened against the SPAC which: (i) seek to restrain,
enjoin or prevent the consummation of the transactions contemplated by this Agreement or (ii) question the validity or legality of
any such transactions or seek to recover damages or to obtain other relief in connection with any such transactions.

 

		(h)	The Class A Shares issuable upon conversion of the Transferred Shares have been duly authorized and reserved for issuance upon
such conversion.

 

		Section
                            3.	Representations and Warranties
of the Sponsor. The Sponsor hereby represents and warrants to the Investor, as follows:

 

		(a)	The Sponsor is duly organized and in good standing (to the extent applicable) under its jurisdiction of organization and has full
power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated
hereby.

 

		(b)	This Agreement has been duly and validly executed and delivered by the Sponsor and constitutes a legal, valid and binding obligation
of the Sponsor enforceable against the Sponsor in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors’
rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies.

 

		(c)	The execution and delivery of this Agreement, the consummation of the transactions contemplated hereby and the performance by the
Sponsor of its obligations hereunder will not conflict with, or result in any violation of or default under, (i) the organizational
and founding documentation of the Sponsor, (ii) any agreement, indenture or instrument to which the Sponsor is a party or by which
the Transferred Shares are bound or (iii) any law, statute, rule or regulation to which the Sponsor is or the Transferred Shares
are subject.

 

     4

     

    

 

		(d)	No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority is required on the part of the Sponsor in connection with the consummation of the transactions contemplated
by this Agreement.

 

		(e)	There are no actions, suits, investigations or proceedings pending or threatened against the Sponsor which: (i) seek to restrain,
enjoin, prevent the consummation of the transactions contemplated by this Agreement or (ii) question the validity or legality of
any such transactions or seek to recover damages or to obtain other relief in connection with any such transactions.

 

		(f)	Upon issuance in accordance with, and payment pursuant to, the terms hereof, the Investor will have or receive good title to the Transferred
Shares, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder, (ii) transfer
restrictions under federal and state securities laws and (iii) liens, claims or encumbrances imposed due to the actions of the Investor.

 

		(g)	The Sponsor is not, and in connection with this Agreement is not acting as, an agent, representative, intermediary or nominee for
any person identified on the list of blocked persons maintained by the Office of Foreign Assets Control of the U.S. Treasury Department;
and the Sponsor has complied in all material respects with all applicable U.S. laws, regulations, directives and executive orders relating
to anti-money laundering.

 

		Section
                            4.	Representations and Warranties
of the Investor. The Investor hereby represents and warrants to the SPAC and the Sponsor, as follows:

 

		(a)	The Investor has full power and authority to execute and deliver this Agreement and to perform its obligations hereunder.

 

		(b)	This Agreement has been duly and validly executed and delivered by the Investor and constitutes a legal, valid and binding obligation
of the Investor enforceable against the Investor in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors’
rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies.

 

		(c)	The execution and delivery of this Agreement, the consummation of the transactions contemplated hereby and the performance by the
Investor of its obligations hereunder will not materially conflict with, or result in any material violation of or default under, any
agreement or other instrument to which the Investor is a party or by which the Investor is bound, or any decree, order, statute, rule or
regulation applicable to the Investor, in each case except as would not have a material adverse effect on the ability of the Investor
to consummate the transactions contemplated by this Agreement or perform its obligations hereunder.

 

     5

     

    

 

		(d)	No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority is required on the part of the Investor in connection with the consummation of the transactions
contemplated by this Agreement (other than effectiveness of the Registration Statement for the submission of any order in the IPO).

 

		(e)	The Investor is an institutional accredited investor, as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12),
or (a)(13) in Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), and has
such knowledge and experience in financial and business matters that the Investor is capable of evaluating the merits and risks of the
Investor’s investment in the Securities, of making an informed investment decision with respect thereto, and has the ability and
capacity to protect the Investor’s interests.

 

		(f)	The Investor has reviewed the Registration Statement and has had the opportunity to ask questions and receive answers from the officers
and directors of the SPAC concerning the proposed business, management, financial condition and affairs of the SPAC and the terms and
conditions of the IPO, the Units, the Class A Shares, the Warrants and the Founder Shares, and understands the terms and conditions
of the IPO and such securities.

 

		(g)	The Investor understands that the offer and sale of the Transferred Shares to the Investor has not been, and will not be, registered
under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon,
among other things, the bona fide nature of the investment intent and the accuracy of the Investor’s representations as expressed
herein. The Investor understands that the Transferred Shares are “restricted securities” under applicable U.S. federal and
state securities laws and that, pursuant to these laws, the Investor must hold the Transferred Shares indefinitely unless they are registered
with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The
Investor understands that no public market now exists for the Transferred Shares and that the SPAC has made no assurances that a public
market will ever exist for the Transferred Shares. The Investor acknowledges that the SPAC has no obligation to register or qualify the
Transferred Shares for resale except pursuant to the Registration Rights Agreement (as defined below). The Investor further acknowledges
that if an exemption from registration or qualification is available, the exemption may be conditioned on various requirements including
the time and manner of sale, the holding period for the Transferred Shares, and on requirements relating to the SPAC which are outside
of the parties’ control, and which the SPAC is under no obligation and may not be able to satisfy. The Investor understands that
the offering of the Transfer Securities is not, and is not intended to be, part of the IPO, and that the Investor will not be able to
rely on the protection of Section 11 of the Securities Act with respect to the Transferred Shares.

 

     6

     

    

 

		(h)	To the Investor’s knowledge, there are no actions, suits, investigations or proceedings pending or threatened against the Investor
which: (i) seek to restrain, enjoin, prevent the consummation of the transactions contemplated by this Agreement or (ii) question
the validity or legality of any such transactions or seek to recover damages or to obtain other relief in connection with any such transactions.

 

		Section
                            5.	Additional Agreements and Acknowledgements
of the Investor.

 

		(a)	The Investor agrees solely with the SPAC that, without the written consent of the SPAC, the Investor shall not transfer, assign or
sell any Transferred Shares or the Class A Shares issuable upon conversion of the Transferred Shares held by it, until the earlier
of (i) one year after the date the SPAC consummates a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses or entities (a “Business Combination”) and (ii) the
earlier to occur of, subsequent to a Business Combination, (A) the first date on which the last reported sale price of the Class A
Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and
the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the consummation of a Business Combination
and (B) the date on which the SPAC consummates a subsequent liquidation, merger, share exchange or other similar transaction which
results in all of the SPAC’s shareholders having the right to exchange their Class A Shares for cash, securities or other property.
Notwithstanding the foregoing, Transfers of the Founder Shares and the Class A Shares issuable upon conversion of the Founder Shares
are permitted (i) to the SPAC’s officers or directors, any affiliates or family members of any of the SPAC’s officers
or directors, any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor, or any employees of such affiliates;
(ii) by private sales or transfers made in connection with the consummation of a Business Combination at prices no greater than the
price at which the Founder Shares were originally purchased; (iii) by virtue of the Investor’s organizational documents upon
liquidation or dissolution of the Investor; (iv) to the SPAC for no value for cancellation in connection with the consummation of
an initial Business Combination, (v) in the event of the SPAC’s liquidation prior to the completion of a Business Combination;
(vi) in the event of the SPAC’s liquidation, merger, share exchange or other similar transaction which results in all of the
SPAC’s public shareholders having the right to exchange their Class A Shares for cash, securities or other property subsequent
to the completion of an initial Business Combination; or (vii) to the Investor’s controlled affiliates that agree in writing
to be bound by this Agreement with the same duties and obligations of the Investor hereunder; provided, however,
that in the case of clause (i) such permitted transferees must enter into a written agreement agreeing to be bound by these transfer
restrictions and in the case of clause (vii) such controlled affiliates must agree in writing to be bound by this Agreement with
the same duties and obligations of the Investor hereunder. As used herein, “Transfer” shall mean the (A) sale
of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement
to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease
of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and
regulations of the U.S. Securities and Exchange Commission promulgated thereunder with respect to, any security, (B) entry into any
swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security
or (C) public announcement of any intention to effect any transaction specified in clause (A) or (B).

 

     7

     

    

 

		(b)	The Investor hereby agrees that it shall have no right of set off or any right, title, interest or claim of any kind (“Claim”)
to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it
may have now or in the future, except for redemption and liquidation rights, if any, the Investor may have in respect of any Public Shares
held by it. In the event the Investor has any Claim against the Company under this Agreement, the Investor shall pursue such Claim solely
against the Company and its assets outside the Trust Account and not against the property or any monies in the Trust Account, except for
redemption and liquidation rights, if any, the Investor may have in respect of any Public Shares held by it.

 

		(c)	The Investor acknowledges that it is aware the SPAC will establish the Trust Account for the benefit of its public shareholders upon
the closing of the IPO. The Investor agrees that, solely with respect to the Transferred Shares, it has no right, title, interest or claim
of any kind in or to any monies held in the Trust Account, or any other asset of the SPAC as a result of any liquidation of the SPAC.
For the avoidance of doubt, this Section 5(c) shall not limit any right, title, interest or claim of such Investor in
or to the monies held in the Trust Account with respect to Class A Ordinary Shares acquired by such Investor in the IPO or in the
open market in accordance with the terms and conditions applicable to the Class A Ordinary Shares described in the Registration Statement.

 

		(d)	In connection with the IPO, the SPAC shall enter into a registration rights agreement (the “Registration Rights Agreement”)
with the Sponsor, the Investor and certain other parties thereto in the form filed as an exhibit to the SPAC’s Registration Statement.
The Registration Rights Agreement shall provide the Investor with registration rights with respect to the Transferred Shares that are
no less favorable to the Investor than the registration rights of the Sponsor set forth therein.

 

     8

     

    

 

		(e)	Neither the Company nor the Sponsor will, without the written consent of the Investor in each instance, use in advertising, publicity
or otherwise the name of the Investor or any of its affiliates, or any director, officer or employee of the Investor, nor any trade name,
trademark, trade device, service mark, symbol or any abbreviation, contraction or simulation thereof owned by the Investor or its affiliates
or any information relating to the business or operations of the Investor or its affiliates (including, for the avoidance of doubt, any
investment vehicles, funds or accounts managed thereby). Notwithstanding the foregoing, the Company may disclose the Investor’s
name and information concerning the Investor (A) to the extent required by law, regulation or regulatory request, including in the
Registration Statement or (B) to the Company’s lawyers, independent accountants and to other advisors and service providers
who reasonably require the Investor’s information in connection with the provision of services to the Company, are advised of the
confidential nature of such information and are obligated to keep such information confidential. The Company and the Sponsor agree to
provide to the Investor for the its review any disclosure in any registration statement, proxy statement or other document in advance
of the submission, filing or disclosure of such document in connection with the transactions contemplated by this Agreement with respect
to the Investor or any of its affiliates, and will not make any such submission, filing or disclosure without including any revisions
reasonably requested in writing by the Investor or to the extent the Investor has a good faith objection to such submission, filing or
disclosure..

 

		(f)	The Investor hereby agrees that neither it, nor any person or entity acting on its behalf or pursuant to any understanding with it,
will engage in any Short Sales with respect to securities of the Company prior to the Business Combination Closing . For purposes
of this Section 5(f), “Short Sales” shall include, without limitation, all “short sales”
as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges
(other than pledges in the ordinary course of business as part of prime brokerage arrangements) including through total return swaps. For
the avoidance of doubt, this Section 5(f) shall not prohibit an Investor from buying or selling any options or other
derivative securities.

 

Section 6.              Matters
Relating to Restricted Securities.  Following the expiration of the transfer restrictions set forth in Section 5(a) above,
if the Transferred Shares are eligible to be sold without restriction under, and without the SPAC being in compliance with the current
public information requirements of, Rule 144 under the Securities Act, or if they are registered for resale under the Securities
Act pursuant to a resale registration statement, then at the Investor’s written request, the SPAC will request the SPAC’s
transfer agent to remove any transfer restriction legend, subject to compliance by the Investor with the reasonable and customary procedures
for such removal required by the Investor or its transfer agent. In connection therewith, if required by the SPAC’s transfer agent,
the SPAC will promptly cause an opinion of counsel to be delivered to and maintained with its transfer agent, together with any other
authorizations, certificates and directions required by the transfer agent that authorize and direct the transfer agent to issue such
Transferred Shares without any such legend, all at the sole expense of the Investor.

 

     9

     

    

 

		Section
                            7.	Miscellaneous.

 

		(a)	The parties hereto (i) acknowledge that (A) neither the Investor nor any of its affiliates is providing any services to
the SPAC, the Sponsor or their respective affiliates and (B) the Transferred Shares are being issued solely in exchange for the Transfer
Price, which was the result of arms-length negotiations among the parties.

 

		(b)	Each party shall bear its own fees and expenses incurred in connection with this Agreement and the transactions contemplated hereby,
including all fees and expenses of agents, representatives, financial advisors, legal counsel and accountants.

 

		(c)	This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving
effect to its principles or rules of conflicts of law to the extent such principles or rules would require or permit the application
of the laws of another jurisdiction. THE PARTIES HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT
TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY. With respect to any suit, action or proceeding relating to the transactions
contemplated hereby, the undersigned irrevocably submit to the jurisdiction of the United States District Court or, if such court does
not have jurisdiction, the New York state courts located in the Borough of Manhattan, State of New York, which submission shall be exclusive.

 

		(d)	This Agreement may not be amended, modified or waived without the written consent of the parties hereto.

 

		(e)	The rights and obligations under this Agreement may not be assigned by any party hereto without the prior written consent of the other
parties.

 

		(f)	From time to time, at the reasonable request of any of the other parties hereto, each party hereto shall execute and deliver such
additional reasonable and necessary documents and instruments and take such further lawful action as may be reasonably necessary to consummate
and make effective, in the most expeditious manner practicable, the transactions contemplated by this Agreement.

 

		(g)	Any term or provision of this Agreement which is deemed by a court of competent jurisdiction invalid or unenforceable shall be ineffective
to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining rights of the person intended
to be benefited by such provision or any other provisions of this Agreement.

 

     10

     

    

 

		(h)	This Agreement may be executed in two or more counterparts, each of which shall constitute an original, and all of which taken together
shall constitute one and the same instrument. Any signature page delivered by a facsimile machine or electronic mail shall be binding
to the same extent as an original signature page.

 

		(i)	This Agreement, together with the Registration Rights Agreement, substantially in the form to be filed as an exhibit to the Registration
Statement on Form S-1 to be filed in connection with the Company’s IPO, embodies the entire agreement and understanding among
the Investor, the SPAC and the Sponsor with respect to the Transferred Shares and supersedes all prior oral or written agreements and
understandings relating to the Transferred Shares. No statement, representation, warranty, covenant or agreement of any kind not expressly
set forth in this Agreement shall affect, or be used to interpret, change or restrict, the express terms and provisions of this Agreement.

 

		(j)	The rights and obligations under this Agreement may not be assigned by any party hereto without the prior written consent of the other
parties; provided, for the avoidance of doubt, that the purchase by the Anchor’s affiliates in the IPO shall satisfy the
condition precedent to closing set forth in Section 1(b)(i) hereof.

 

		(k)	The parties hereto agree that irreparable damage may occur in the event any provision of this Agreement is not performed in accordance
with the terms hereof, and that the parties shall be entitled to seek specific performance of the terms hereof, in addition to any other
remedy at law, in equity, or otherwise.

 

		(l)	This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs, legal representatives,
successors and permitted assigns.

 

* * * * *

 

     11

     

    

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as
of the date first written above.

 

	 	THE INVESTOR:
	 	 	 
	 	[•]
	 	 	 
	 	By:	 
	 	Name:
	 	Title:
	 	 	 
	 	E-mail:
	 	Attn:
	 	 	 
	 	SPAC:
	 	 	 
	 	Sieger Healthcare Acquisition Corp
	 	 	 
	 	By:	 
	 	Name: Xuan Sun
	 	Title: Chief Executive Officer
	 	 	 
	 	SPONSOR:
	 	 	 
	 	Sieger Healthcare LLC
	 	 	 
	 	By:	 
	 	Name:
	 	Title:

 

Signature Page to Investment AgreementExhibit 10.1

 

BACKSTOP AGREEMENT

 

This Backstop Facility Agreement
(this “Agreement”) is entered into as of January 6, 2022 by and between CC
Neuberger Principal Holdings III, a Cayman Islands exempted company (the “Company”),
and Neuberger Berman Opportunistic Capital Solutions Master Fund L.P., a Cayman Islands exempted limited partnership (the “Purchaser”).
Capitalized terms used but not initially defined in this Agreement shall have the meaning hereinafter ascribed to such terms.

 

WHEREAS, the Purchaser and
CC Capital Partners, LLC (“CC Capital”) have collectively sponsored a series of publicly traded special purpose acquisition
companies (each such sponsored special purpose acquisition company, a “CC SPAC”), and the related sponsor vehicles
for each such CC SPAC (each, a “Sponsor Vehicle”), for the purpose of each such CC SPAC effecting a merger, share exchange,
asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business
Combination”);

 

WHEREAS, an allocation of
$300,000,000.00 (the “Initial Allocation Amount”, which amount is subject to adjustment in accordance with Section
1(a) below), of committed capital of the Purchaser has been made to backstop redemptions of each CC SPAC on a first come first serve basis
in accordance with the terms of this Agreement;

 

WHEREAS, as a result of the
allocation of the Initial Allocation Amount, the Purchaser is now entering into this Agreement with the Company, whereby upon consummation
of the Business Combination with respect to the Company (the “Closing”), the Purchaser will acquire Class A Ordinary
Shares (or a successor security thereto) of the Company, and the Company will issue and sell to the Purchaser, on a private placement
basis, solely to the extent necessary to fund redemptions of Class A Ordinary Shares (the “Buyer Share Redemptions”)
on a share for share basis, in the amount determined pursuant to Section 2(a)(i) hereof and subject to the limitations set forth herein
(the “Backstop Purchase Shares”); and

 

WHEREAS, the Purchaser expects
to enter (or has entered) into an agreement with each CC SPAC other than the Company (each, an “Other SPAC”) in the
form of this Agreement (except with respect to changes which would not adversely affect the rights of the Company, which would include,
for the avoidance of doubt, more favorable provisions to the Other SPAC regarding the Utilization Limit or utilization priority) which
will provide for the acquisition of common stock of such Other SPAC by the Purchaser in order to fund redemptions by shareholders of such
Other SPAC (each, an “Other Backstop Agreement”).

 

NOW, THEREFORE, in consideration
of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

 

1.                  
Notifications of Available Amount; Utilization Request.

 

(a)                
Utilization Limit. The Purchaser shall never be required to fund an amount (or pay a BPS Purchase Price (as defined
below)) pursuant to this Agreement greater than the sum of, at any time, (i) the Initial Allocation Amount, plus (ii) any additional
allocation of committed capital made available to backstop redemptions of CC SPACs by CC Capital and the Purchaser in their sole discretion
(if so made, an “Additional Allocation”), minus (iii) the amount of any utilization by an Other SPAC pursuant
to an Other Backstop Agreement which utilization was notified to the Purchaser prior to the date a Utilization Notice was delivered pursuant
to Section 1(c) hereunder (which amount, as deducted by this clause (iii), may in no event exceed $300,000,000.00 for the Company or any
single Other SPAC) (such amount, the “Utilization Limit”); provided, that in no event shall the Utilization Limit ever
be an amount in excess of $300,000,000.00.

 

(b)                Notification
of Utilization Limit. Promptly upon the Company’s request, the Purchaser shall notify the Company of the then-current
Utilization Limit (including changes resulting from (i) an Additional Allocation having been made or (ii) any Other SPAC having
delivered a utilization notice to the Purchaser pursuant to an Other Backstop Agreement), and such notification shall include: (A)
the amount of such Additional Allocation or the amount required to be subscribed in accordance with such utilization notice
delivered under an Other Backstop Agreement, as appropriate, and (B) the resulting Utilization Limit. The Utilization Limit at any
time shall be calculated only in accordance with Section 1(a). For purposes of this Agreement, “Business Day”
means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on which banking institutions are
generally authorized or required by law or regulation to close in the City of New York, New York.

 

     

     

    

 

(c)                
Notification of Utilization. On the date by which Buyer Share Redemptions are required to be made in accordance with
the Company’s memorandum and articles of association, as they may be amended from time to time (the “Memorandum and Articles”)
(which date shall be at least two (2) Business Days prior to the date on which the Company’s shareholder meeting with respect to
a Business Combination occurs), to the extent the Company has greater than zero (0) Buyer Share Redemptions and the amount of any alternative
equity financing is less than the amount required to fund Buyer Share Redemptions, the Company shall deliver a written notice (the “Utilization
Notice”) to the Purchaser setting forth: (i) the total number of Class A Ordinary Shares of the Company subject to Buyer Share
Redemptions, (ii) the number of Class A Ordinary Shares (or successor security thereto) the Company is requiring the Purchaser to subscribe
for in accordance with Section 2(a) of this Agreement, which number shall in no event be greater than the lesser of (x) an amount equal
to (1) the then current Utilization Limit (which information shall be promptly provided by Purchaser to the Company upon request or otherwise
in accordance with Section 1(a) hereof) divided by (2) $10.00 and (y) the total number of Class A Ordinary Shares subject to Buyer
Share Redemptions (the “Subscription Amount”), (iii) the resulting BPS Purchase Price (as calculated in accordance
with Section 2(a)(i)) and (iv) the Company’s wire instructions. If the Company fails to deliver a Utilization Notice on the date
set forth in the prior sentence, the Company may provide a Utilization Notice after such date, but not later than twelve (12) Business
Days prior to the Closing Date. The Company shall not be permitted to deliver a Utilization Notice or cause the Purchaser to acquire any
Backstop Purchase Shares to the extent (i) the Company does not have any Class A Ordinary Shares subject to Buyer Share Redemptions or
(ii) the then-current Utilization Limit is $0. Only one (1) Utilization Notice may be delivered hereunder. For the avoidance of doubt,
(x) to the extent the proceeds of alternative equity financings, if any, are in an amount sufficient to fund all of the Company’s
Buyer Share Redemptions, the Company shall not deliver a Utilization Notice hereunder and the Purchaser shall not be required to purchase
any securities hereunder and (y) the Company shall not cause the Purchaser to subscribe for a number of Backstop Purchase Shares greater
than the Subscription Amount necessary to fund the Company’s Buyer Share Redemptions after taking into account any such alternative
equity financing, and in no event shall the Purchaser be required to purchase any such Backstop Purchase Shares.

 

(d)               
Utilization Priority. In no event will a CC SPAC (including the Company) be permitted to deliver a Utilization Notice
prior to the time by which shareholders of such CC SPAC are required to deliver notice to such CC SPAC of the election to require shareholder
redemptions (including Buyer Share Redemptions, which respect to the Company) in accordance with such CC SPAC’s governing documents,
and any utilization notice (including a Utilization Notice hereunder) delivered prior to such time shall be deemed void and shall not
(i) require the Purchaser to purchase any shares (including Class A Ordinary Shares) in such CC SPAC (including the Company) (or successor
security thereto) or (ii) reduce the utilization limit for any CC SPAC (including the Utilization Limit for the Company).

 

2.                  
Sale and Purchase.

 

(a)                
Backstop Purchase Shares.

 

(i)                 
Subject to the terms and conditions hereof, solely in the event of the valid delivery of the Utilization Notice by the Company
to the Purchaser hereunder, the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company a number
of Backstop Purchase Shares equal to the Subscription Amount for an aggregate purchase price of $10.00 per share multiplied by the number
of Backstop Purchase Shares issued and sold hereunder (such aggregate purchase price, the “BPS
Purchase Price”). In no event will the BPS Purchase Price be greater than the lesser of (x) the then-current Utilization
Limit and (y) the total number of Class A Ordinary Shares subject to Buyer Share Redemptions multiplied by $10.00.

 

(ii)               
The valid delivery of the Utilization Notice hereunder shall serve as notice to the Purchaser that the Purchaser will be
required to pay the BPS Purchase Price, and acquire the Backstop Purchase Shares, at the BPS Closing (as defined below).

 

    2

     

    

 

(iii)             
 The closing of the sale of the Backstop Purchase Shares (the “BPS Closing”)
shall be held on the same date and immediately prior to the Closing (such date being referred to as the “Closing
Date”); provided, however, that unless consented to in writing by the Purchaser, the BPS Closing shall
not occur prior to the twelfth (12th) Business Day following the Purchaser’s receipt of the Utilization Notice. At the BPS Closing,
the Company will issue to the Purchaser the Backstop Purchase Shares, registered in the name of the Purchaser, against (and concurrently
with) the payment of the BPS Purchase Price to the Company by wire transfer of immediately available funds to the account notified to
the Purchaser by the Company in the Utilization Notice. If the Closing does not occur within thirty (30) days after the Purchaser delivers
the BPS Purchase Price to the Company, the Company shall return to the Purchaser the BPS Purchase Price; provided that
the return of the BPS Purchase Price shall not terminate this Agreement or otherwise relieve either party of any of its obligations hereunder.

 

(b)               
Delivery of Backstop Purchase Shares.

 

(i)                 
The Company shall register the Purchaser as the owner of the Backstop Purchase Shares purchased by the Purchaser hereunder
(individually or collectively, the “Securities”) in the register of members
of the Company and with the Company’s transfer agent by book-entry on or promptly after (but in no event more than two (2) Business
Days after) the date of the BPS Closing.

 

(ii)               
Each register and book-entry for the Backstop Purchase Shares purchased by the Purchaser hereunder shall contain a notation,
and each certificate (if any) evidencing the Backstop Purchase Shares shall be stamped or otherwise imprinted with a legend, in substantially
the following form:

 

“THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND
MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.”

 

(c)                
Legend Removal. If the Backstop Purchase Shares are eligible to be sold without restriction under, and without the
Company being in compliance with the current public information requirements of, Rule 144 under the Securities Act of 1933, as amended
(the “Securities Act”), then at the Purchaser’s request, the Company
will, at its sole expense, cause the Company’s transfer agent to remove the legend set forth in Section 2(b)(ii) hereof. In connection
therewith, if required by the Company’s transfer agent, the Company will promptly cause an opinion of counsel to be delivered to
and maintained with its transfer agent, together with any other authorizations, certificates and directions required by the transfer agent,
that authorize and direct the transfer agent to transfer such Backstop Purchase Shares without any such legend; provided, however,
that the Company will not be required to deliver any such opinion, authorization or certificate or direction if it reasonably believes
that removal of the legend could reasonably be expected to result in or facilitate transfers of Backstop Purchase Shares in violation
of applicable law.

 

(d)               
Registration Rights. The Purchaser shall have registration rights with respect to the Backstop Purchase Shares as
set forth on Exhibit A (the “Registration Rights”).

 

3.                  
Representations and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as follows, as of the
date hereof:

 

(a)                
Organization and Power. The Purchaser is duly organized, validly existing, and in good standing under the laws of
the jurisdiction of its formation (if the concept of “good standing” is a recognized concept in such jurisdiction) and has
all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b)                Authorization.
The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the
Purchaser, will constitute the valid and legally binding obligation of the Purchaser, enforceable in accordance with its terms,
except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of
general application affecting enforcement of creditors’ rights generally, (b) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies, or (c) to the extent the indemnification provisions
contained in the Registration Rights may be limited by applicable federal or state securities laws.

 

    3

     

    

 

(c)                
Governmental Consents and Filings. No consent, approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Purchaser in
connection with the consummation of the transactions contemplated by this Agreement.

 

(d)               
Compliance with Other Instruments. The execution, delivery and performance by the Purchaser of this Agreement and
the consummation by the Purchaser of the transactions contemplated by this Agreement will not result in any violation or default (i) of
any provisions of its organizational documents, if applicable, (ii) of any instrument, judgment, order, writ or decree to which it is
a party or by which it is bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under
any lease, agreement, contract or purchase order to which it is a party or by which it is bound or (v) of any provision of federal or
state statute, rule or regulation applicable to the Purchaser, in each case (other than clause (i)), which would have a material adverse
effect on the Purchaser or its ability to consummate the transactions contemplated by this Agreement.

 

(e)                
Purchase Entirely for Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s
representation to the Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities
to be acquired by the Purchaser will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and
not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting
any participation in, or otherwise distributing the same in violation of law. By executing this Agreement, the Purchaser further represents
that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant
participations to such Person or to any third Person, with respect to any of the Securities. If the Purchaser was formed for the specific
purpose of acquiring the Securities, each of its equity owners is an accredited investor as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act. For purposes of this Agreement, “Person” means an
individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other
entity or any government or any department or agency thereof.

 

(f)                 
Disclosure of Information. The Purchaser has had an opportunity to discuss the Company’s business, management,
financial affairs and the terms and conditions of the sale of the Securities with the Company’s management.

 

(g)               
Restricted Securities. The Purchaser understands that the sale of the Securities to the Purchaser has not been, and
will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities
Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations
as expressed herein. The Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal
and state securities laws and that, pursuant to these laws, the Purchaser must hold the Securities indefinitely unless they are registered
with the Securities and Exchange Commission (the “SEC”) and qualified by state authorities, or an exemption from such
registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or
qualify the Securities for resale, except pursuant to the Registration Rights. The Purchaser further acknowledges that if an exemption
from registration or qualification is available, it may be conditioned on various requirements, including the time and manner of sale,
the holding period for the Securities, and requirements relating to the Company which are outside of the Purchaser’s control, and
which the Company is under no obligation and may not be able to satisfy. The Purchaser acknowledges that the Company filed a Registration
Statement for its initial public offering (“IPO”) with the SEC. The Purchaser understands that the sale of the Securities
hereunder is not, and is not intended to be, part of the IPO, and that the Purchaser will not be able to rely on the protection of Section
11 of the Securities Act with respect to such sale of the Securities.

 

(h)               
High Degree of Risk. The Purchaser understands that its agreement to purchase the Securities involves a high degree
of risk which could cause the Purchaser to lose all or part of its investment.

 

(i)                 
Accredited Investor. The Purchaser is an “accredited investor” as defined in Rule 501(a) of Regulation
D promulgated under the Securities Act.

 

    4

     

    

 

(j)                 
 Foreign Investors. If the Purchaser is not a United States person (as defined by Section 7701(a)(30) of the U.S.
Internal Revenue Code of 1986, as amended), the Purchaser hereby represents that it has satisfied itself as to the full observance of
the laws of its jurisdiction in connection with any invitation to subscribe for the Securities or any use of this Agreement, including
(i) the legal requirements within its jurisdiction for the purchase of the Securities, (ii) any foreign exchange restrictions applicable
to such purchase, (iii) any governmental or other consents that may need to be obtained, and (iv) the income tax and other tax consequences,
if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Securities. The Purchaser’s subscription
and payment for and continued beneficial ownership of the Securities will not violate any applicable securities or other laws of the Purchaser’s
jurisdiction.

 

(k)               
No General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders
or partners has either directly or indirectly, including, through a broker or finder to its knowledge, engaged in any general solicitation,
or published any advertisement, in each case in connection with its purchase of the Securities.

 

(l)                 
Residence. The principal place of business of the Purchaser’s general partner is the office located at the
address of the Purchaser set forth in Section 8(a) below.

 

(m)              
Non-Public Information. The Purchaser acknowledges its obligations under applicable securities laws with respect
to the treatment of material non-public information relating to the Company.

 

(n)               
Adequacy of Financing. The Purchaser has, or will have at the BPS Closing, available to it sufficient funds to satisfy
its obligations under this Agreement. As of the date hereof, the Utilization Limit is the Initial Allocation Amount.

 

(o)               
Affiliation of Certain FINRA Members. The Purchaser is neither a person associated nor affiliated with any underwriter
of the IPO of the Company or, to its actual knowledge, any other member of the Financial Industry Regulatory Authority (“FINRA”)
that participated in the IPO of the Company.

 

(p)               
No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained
in this Section 3 and in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf
of the Purchaser nor any of the Purchaser’s affiliates (the “Purchaser Parties”)
has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Purchaser and the
sale and purchase of the Securities, and the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations
and warranties expressly made by the Company in Section 4 of this Agreement and in any certificate or agreement delivered pursuant hereto,
the Purchaser Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made
by the Company, any person on behalf of the Company or any of the Company’s affiliates (collectively, the “Company
Parties”). Notwithstanding anything to the contrary in this Agreement, nothing in this Section 3(p) shall limit any claim
or cause of action (or recovery in connection therewith) with respect to fraud.

 

4.                  
Representations and Warranties of the Company. The Company represents and warrants to the Purchaser as follows:

 

(a)                
Incorporation and Corporate Power. The Company is an exempted company duly incorporated and validly existing and
in good standing under the laws of the Cayman Islands and has all requisite corporate power and authority to carry on its business as
presently conducted and as proposed to be conducted. The Company has no subsidiaries.

 

(b)               
Capitalization. The authorized share capital of the Company consists, as of the date hereof, of:

 

(i)                 
500,000,000 Class A Ordinary Shares, 40,250,000 of which are issued and outstanding;

 

    5

     

    

 

(ii)               
 50,000,000 Class B ordinary shares of the Company, par value $0.0001 per share, 15,062,500 of which are issued and outstanding;
and all of the outstanding Class B ordinary shares of the Company have been duly authorized, are fully paid and nonassessable and were
issued in compliance with all applicable laws; and

 

(iii)             
1,000,000 preference shares, none of which are issued and outstanding.

 

(c)                
Authorization. All corporate action required to be taken by the Company’s Board of Directors and shareholders
in order to authorize the Company to enter into this Agreement, and to issue the Backstop Purchase Shares at the BPS Closing has been
taken or will be taken prior to the BPS Closing, as applicable. All action on the part of the shareholders, directors and officers of
the Company necessary for the execution and delivery of this Agreement, the performance of all obligations of the Company under this Agreement
to be performed as of the BPS Closing, and the issuance and delivery of the Backstop Purchase Shares and the securities issuable upon
conversion or exercise of the Backstop Purchase Shares has been taken or will be taken prior to the BPS Closing, as applicable. This Agreement,
when executed and delivered by the Company, shall constitute the valid and legally binding obligation of the Company, enforceable against
the Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (iii) to the
extent the indemnification provisions contained in the Registration Rights may be limited by applicable federal or state securities laws.

 

(d)               
Valid Issuance of Backstop Purchase Shares.

 

(i)                 
The Backstop Purchase Shares, when issued, sold and delivered in accordance with the terms and for the consideration set
forth in this Agreement and registered in the register of members of the Company, will be validly issued, fully paid and nonassessable
and free of all preemptive or similar rights, liens, encumbrances and charges with respect to the issue thereof and restrictions on transfer
other than restrictions on transfer specified under this Agreement, applicable state and federal securities laws and liens or encumbrances
created by or imposed by the Purchaser. Assuming the accuracy of the representations of the Purchaser in this Agreement and subject to
the filings described in Section 4(e) below, the Backstop Purchase Shares will be issued in compliance with all applicable federal and
state securities laws.

 

(ii)               
No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification
Event”) is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below),
except for a Disqualification Event as to which Rule 506(d)(2)(ii)–(iv) or (d)(3), is applicable. “Company
Covered Person” means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under
the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

 

(e)                
Governmental Consents and Filings. Assuming the accuracy of the representations and warranties made by the Purchaser
in this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing
with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of
the transactions contemplated by this Agreement, except for any filings pursuant to Regulation D of the Securities Act, applicable state
securities laws, and pursuant to the Registration Rights.

 

(f)                 
Compliance with Other Instruments. The execution, delivery and performance of this Agreement and the consummation
of the transactions contemplated by this Agreement by the Company will not result in any violation or default (i) of any provisions of
the Company’s Memorandum and Articles or its other governing documents, (ii) of any instrument, judgment, order, writ or decree
to which the Company is a party or by which the Company is bound, (iii) under any note, indenture or mortgage to which the Company is
a party or by which the Company is bound, (iv) under any lease, agreement, contract or purchase order to which the Company is a party
or by which the Company is bound or (v) of any provision of federal or state statute, rule or regulation applicable to the Company, in
each case (other than clause (i)) which would have a material adverse effect on the Company or its ability to consummate the transactions
contemplated by this Agreement.

 

    6

     

    

 

(g)               
 Operations. As of the date hereof, the Company has not conducted any operations other than organizational activities
and activities in connection with its IPO, its search for a Business Combination and financing in connection therewith.

 

(h)               
Foreign Corrupt Practices. Neither the Company, nor, to the knowledge of the Company, any director, officer, agent,
employee or other Person acting on behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used
any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii)
made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated
or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate,
payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee.

 

(i)                 
Compliance with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times
in compliance with applicable financial recordkeeping and reporting requirements and all applicable U.S. and non-U.S. anti-money laundering
laws, rules and regulations, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot
Act of 2001 and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any
related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

(j)                 
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public
board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting
the Company or any of the Company’s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities
as such.

 

(k)               
No General Solicitation. Neither the Company, nor any of its officers, directors, employees, agents or shareholders
has either directly or indirectly, including through a broker or finder, engaged in any general solicitation, or published any advertisement,
in each case in connection with the sale of the Backstop Purchase Shares.

 

(l)                 
No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained
in this Section 4 and in any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall
be deemed to make any other express or implied representation or warranty with respect to the Company, the sale and purchase of the Backstop
Purchase Shares, the IPO or a potential Business Combination, and the Company Parties disclaim any such representation or warranty. Except
for the specific representations and warranties expressly made by the Purchaser in Section 3 of this Agreement and in any certificate
or agreement delivered pursuant hereto, the Company Parties specifically disclaim that they are relying upon any other representations
or warranties that may have been made by any of the Purchaser Parties. Notwithstanding anything to the contrary in this Agreement, nothing
in this Section 4(l) shall limit any claim or cause of action (or recovery in connection therewith) with respect to fraud.

 

5.                  
Additional Agreements, Acknowledgements and Waivers of the Purchaser.

 

(a)                
Trust Account.

 

(i)                 
The Purchaser hereby acknowledges that it is aware that the Company has established a trust account (the “Trust
Account”) for the benefit of its public shareholders in connection with the closing of the Company’s IPO. The Purchaser,
for itself and its affiliates, hereby agrees that it has no right, title, interest or claim of any kind in or to any monies held in the
Trust Account, or any distributions therefrom, or any other asset of the Company as a result of any liquidation of the Company, except
for redemption and liquidation rights, if any, the Purchaser may have in respect of any Class A Ordinary Shares issued in the IPO (the
 “Public Shares”) held by it.

 

    7

     

    

 

(ii)               
 The Purchaser hereby agrees that it shall have no right of set-off or any right, title, interest or claim of any kind (“Claim”)
to, or to any monies in, the Trust Account, or any distributions therefrom and hereby irrevocably waives any Claim to, or to any monies
in, the Trust Account, or any distributions therefrom, that it may have now or in the future, except for redemption and liquidation rights,
if any, the Purchaser may have in respect of any Public Shares held by it. In the event the Purchaser has any Claim against the Company
under this Agreement, the Purchaser shall not pursue such Claim against the Trust Account or against the property or any monies in the
Trust Account, or any distributions therefrom, except for redemption and liquidation rights, if any, the Purchaser may have in respect
of any Public Shares held by it.

 

(b)               
No Short Sales. The Purchaser hereby agrees that neither it, nor any person or entity acting on its behalf or pursuant
to any understanding with it, will engage in any Short Sales with respect to securities of the Company prior to the Business Combination
Closing. For purposes of this Section 4(b), “Short Sales” shall include all
 “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Securities Exchange Act of 1934, as amended,
and all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage or
borrowing arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis),
and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers.

 

(c)                
Other Backstop Agreement. In the event the Purchaser enters into an Other Backstop Agreement with an Other SPAC prior
to the Closing, such Other Backstop Agreement shall be in the form of this Agreement (with only such changes as necessary to reflect such
Other SPAC is the “Company” under the “Agreement” or such other changes as would not affect the Company’s
ability to be first to issue a Utilization Notice in accordance with the terms hereof).

 

6.                  
BPS Closing Conditions.

 

(a)                
The obligation of the Purchaser to purchase the Backstop Purchase Shares at the BPS Closing under this Agreement shall be
subject to the fulfillment, at or prior to the BPS Closing of each of the following conditions, any of which, to the extent permitted
by applicable laws, may be waived by the Purchaser:

 

(i)                 
The Business Combination shall be consummated substantially concurrently with, and immediately following, the purchase of
the Backstop Purchase Shares;

 

(ii)               
The representations and warranties of the Company set forth in Section 4 of this Agreement shall have been true and correct
as of the date hereof and shall be true and correct as of the BPS Closing, as applicable, with the same effect as though such representations
and warranties had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a
specified date, which shall be true and correct as of such specified date), except where the failure to be so true and correct would not
have a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement;

 

(iii)             
The Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the BPS Closing;

 

(iv)              
The then-current Utilization Limit shall be greater than $0;

 

(v)               
The Company shall have greater than zero (0) Class A Ordinary Shares subject to redemptions in accordance with its Memorandum
and Articles, which redemptions have not been withdrawn, for which no alternative equity financing sources have been identified;

 

(vi)              
Investors (direct and indirect) of the Purchaser with opt-out rights shall not have exercised such opt-out rights in respect
of the Business Combination; and

 

(vii)             No
order, writ, judgment, injunction, decree, determination, or award shall have been entered or threatened by or with any
governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal
restraint or prohibition shall be in effect or threatened, that makes the consummation of the transactions contemplated hereby
illegal or prevents the consummation of the transactions contemplated hereby.

 

    8

     

    

 

(b)               
The obligation of the Company to sell the Backstop Purchase Shares at the BPS Closing under this Agreement shall be subject
to the fulfillment, at or prior to the BPS Closing of each of the following conditions, any of which, to the extent permitted by applicable
laws, may be waived by the Company:

 

(i)                 
The Business Combination shall be consummated substantially concurrently with, and immediately following, the purchase of
the Backstop Purchase Shares;

 

(ii)               
The representations and warranties of the Purchaser set forth in Section 3 of this Agreement shall have been true and correct
as of the date hereof and shall be true and correct as of the BPS Closing, as applicable, with the same effect as though such representations
and warranties had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a
specified date, which shall be true and correct as of such specified date), except where the failure to be so true and correct would not
have a material adverse effect on the Purchaser or its ability to consummate the transactions contemplated by this Agreement;

 

(iii)             
The Purchaser shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Purchaser at or prior to the BPS Closing; and

 

(iv)              
No order, writ, judgment, injunction, decree, determination, or award shall have been entered or threatened by or with any
governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint
or prohibition shall be in effect or threatened, that makes the consummation of the transactions contemplated hereby illegal or prevents
the consummation of the transactions contemplated hereby.

 

7.                  
Termination. This Agreement may be terminated at any time prior to the BPS Closing:

 

(a)                
by written consent of each of the Company and the Purchaser; or

 

(b)               
automatically:

 

(i)                 
upon the consummation of the Business Combination (whether or not a Utilization Notice has been delivered and Backstop Purchase
Shares have been purchased hereunder); or

 

(ii)               
if a Business Combination is not consummated within 24 months from the closing of the IPO, or such later date as may be
approved by the Company’s shareholders in accordance with the Memorandum and Articles.

 

In the event of any termination
of this Agreement pursuant to this Section 7, the BPS Purchase Price, if previously paid, and all Purchaser’s funds paid in connection
herewith shall be promptly returned to the Purchaser in accordance with written instructions provided by the Purchaser to the Company,
and thereafter this Agreement shall forthwith become null and void and have no effect, without any liability on the part of the Purchaser
or the Company and their respective directors, officers, employees, partners, managers, members, or shareholders and all rights and obligations
of each party shall cease; provided, however, that nothing contained in this Section 7 shall relieve either party from liabilities
or damages arising out of any fraud or willful breach by such party of any of its representations, warranties, covenants or agreements
contained in this Agreement. Section 5(a) shall survive termination of this Agreement.

 

    9

     

    

 

8.                  
General Provisions.

 

(a)                
Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall
be deemed effectively given upon the earlier of actual receipt, or (a) personal delivery to the party to be notified, (b) when sent,
if sent by electronic mail or facsimile (if any) during normal business hours of the recipient, and if not sent during normal business
hours, then on the recipient’s next Business Day, (c) five (5) Business Days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one (1) Business Day after deposit with a nationally recognized overnight courier,
freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company
shall be sent to: CC Neuberger Principal Holdings III, 200 Park Avenue, 58th Floor, New York, New York 10166, Attn: Douglas Newton, email:
newton@cc.capital, with a copy to the Company’s counsel at: Kirkland & Ellis LLP, 601 Lexington Avenue, New York, New
York 10022, Attn: Christian O. Nagler, Esq., Lauren M. Colasacco, P.C., and Peter S. Seligson, Esq., email: cnagler@kirkland.com,
  lauren.colasacco@kirkland.com and peter.seligson@kirkland.com, fax: (212) 446-4900.

 

All communications to the
Purchaser shall be sent to Neuberger Berman Opportunistic Capital Solutions Master Fund L.P., c/o Neuberger Berman Investment Advisers
LLC, 1290 Avenue of the Americas, New York, New York 10104, Attention: Vanessa Rosenthal, Ralph DeFeo and Ephraim Lemberger, email: vanessa.rosenthal@nb.com,
  ralph.defeo@nb.com and ephraim.lemberger@nb.com, or to such e-mail address, facsimile number (if any) or address
as subsequently modified by written notice given in accordance with this Section 8(a).

 

(b)               
No Finder’s Fees. Other than fees payable to the underwriters of the IPO or any other investment bank or financial
advisor who assists the Company in sourcing targets for a Business Combination, which fees shall be the responsibility of the Company,
each party represents that it neither is nor will be obligated for any finder’s fee or commission in connection with this transaction.
The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature
of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability
or asserted liability) for which the Purchaser or any of its officers, employees or representatives is responsible. The Company agrees
to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in the nature of a finder’s or
broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability)
for which the Company or any of its officers, employees or representatives is responsible.

 

(c)                
Entire Agreement. This Agreement, together with any documents, instruments and writings that are delivered pursuant
hereto or referenced herein, constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the
extent they relate in any way to the subject matter hereof or the transactions contemplated hereby.

 

(d)               
No Third Party Beneficiaries. This letter shall be binding on, and inure solely to the benefit of, the parties hereto
and their respective successors and assigns, and nothing set forth in this letter shall be construed to confer upon or give any Person,
other than the parties hereto and their respective successors and permitted assigns, any benefits, rights or remedies under or by reason
of, or any rights to enforce or cause the Company to enforce, this Agreement.

 

(e)                
Successors. All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement
are binding upon, and inure to the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this
Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns
any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

(f)                Assignments.
Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests,
or obligations hereunder without the prior written consent of the other party. Notwithstanding the foregoing, the Purchaser may
assign and delegate all or a portion of its rights and obligations to purchase the Backstop Purchase Shares to one or more other
persons upon the consent of the Company (which consent shall not be unreasonably conditioned, withheld or delayed); provided, however,
that no consent of the Company shall be required if such assignment or delegation is to an affiliate of the Purchaser; provided, further,
that no such assignment or delegation shall relieve the Purchaser of its obligations hereunder (including its obligation to purchase
the Backstop Purchase Shares) and the Company shall be entitled to pursue all rights and remedies against the Purchaser subject to
the terms and conditions hereof. Any purported assignment or assumption of this Agreement or any right or obligation hereunder in
contravention of this Section 8(f) shall be void ab initio.

 

    10

     

    

 

(g)               
Counterparts. This Agreement may be executed in two or more counterparts, each of which will be deemed an original
but all of which together will constitute one and the same instrument.

 

(h)               
Headings. The section headings contained in this Agreement are inserted for convenience only and will not affect
in any way the meaning or interpretation of this Agreement.

 

(i)                 
Governing Law. This Agreement, the entire relationship of the parties hereto, and any dispute between the parties
(whether grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant
to the laws of the State of New York, without giving effect to its choice of laws principles.

 

(j)                 
Jurisdiction. The parties (i) hereby irrevocably and unconditionally submit exclusively to the jurisdiction of the
state courts of New York located in the Borough of Manhattan and to the jurisdiction of the United States District Court for the Southern
District of New York for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not
to commence any suit, action or other proceeding arising out of or based upon this Agreement except in state courts of New York located
in the Borough of Manhattan or the United States District Court for the Southern District of New York, and (iii) hereby waive, and agree
not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the
suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this
Agreement or the subject matter hereof may not be enforced in or by such court.

 

(k)               
Waiver of Jury Trial. The parties hereto hereby waive any right to a jury trial in connection with any litigation
pursuant to this Agreement and the transactions contemplated hereby.

 

(l)                 
Amendments. This Agreement may not be amended, modified, waived or supplemented as to any particular provision, except
with the prior written consent of each of the Company and the Purchaser.

 

(m)              
Waiver of Damages. Notwithstanding anything to the contrary contained herein, in no event shall any party be liable
for consequential, special, exemplary or punitive damages in connection with this Agreement.

 

(n)               
Severability. The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of
any provision will not affect the validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement,
as applied to any party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable
in accordance with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination
will have the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific
words or phrases, and in its reduced form, such provision will then be enforceable and will be enforced.

 

(o)               
Expenses. Each of the Company and the Purchaser will be responsible for payment of its own costs and expenses incurred
in connection with the preparation, execution and performance of this Agreement and the consummation of the transactions contemplated
hereby, including all fees and expenses of agents, representatives, financial advisors, legal counsel and accountants. The Company shall
be responsible for the fees of its transfer agent, stamp taxes and all of The Depository Trust Company’s fees associated with the
issuance and resale of the Securities and the securities issuable upon conversion or exercise of the Securities.

 

    11

     

    

 

(p)                Construction.
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of
intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or
burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement.
Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and
regulations promulgated thereunder, unless the context requires otherwise. The words “include,”
 “includes,” and “including” will be deemed to be followed by “without
limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words
in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words
 “this Agreement,” “herein,” “hereof,” “hereby,”
 “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision
unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will have
independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any
respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of
the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such
party hereto is in breach of the first representation, warranty, or covenant.

 

(q)               
Waiver. No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder,
whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant
hereunder or affect in any way any rights arising because of any prior or subsequent occurrence.

 

(r)                 
Specific Performance; Enforcement. The Purchaser agrees that irreparable damage may occur in the event any provision
of this Agreement was not performed by the Purchaser in accordance with the terms hereof and that the Company shall be entitled to specific
performance of the terms hereof, in addition to any other remedy at law or equity, without a requirement to post bond or any other security.
This Agreement may be enforced only by the Company and the Purchaser, and none of the Company’s direct or indirect creditors nor
any other person that is not a party to this Agreement shall have any right to enforce this Agreement or to cause the Company to enforce
this Agreement.

 

[Signature Page Follows]

 

    12

     

    

 

IN WITNESS WHEREOF,
the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

CC NEUBERGER PRINCIPAL HOLDINGS III

 

	By:	/s/ Matthew Skurbe	 
	Name:	Matthew Skurbe	 
	Title:	Chief Financial Officer	 

 

NEUBERGER BERMAN OPPORTUNISTIC CAPITAL SOLUTIONS
MASTER FUND L.P.

 

By: Neuberger Berman Investment Advisers LLC,
as investment adviser

 

	By:	/s/ Charles Kantor	 
	Name:	Charles Kantor	 
	Title:	Managing Director	 

 

[Signature Page to Backstop
Facility Agreement]

 

     

     

    

 

Exhibit A

Registration Rights

 

To be the same Registration Rights to which the
Purchaser is entitled with respect to the Purchaser’s Forward Purchase Agreement with the Company (but including the Backstop Purchase
Shares).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]